Authors: Jahan Ara Ainuddin, Anjum Ara Hasan, Shaista Naz, Lubna Irshad
Abstract
To assess the effectiveness of 17 hydroxy progesterone in prevention of
preterm labour in women with history of previous preterm labour and with threatened
preterm labour in this pregnancy. Design: case control clinical trial. Place And Duration: Private obstetric clinics, Lyari General Hospital and Hamdard University Hospital January 2006 till August 2009. Patients And Methods: The Study was done on women with singleton live pregnancy with history of previous preterm delivery or with threatened preterm labour in this pregnancy. 5o patients were selected and given weekly injection of hydro xy progesterone starting from 14-20 weeks of pregnancy and continued for 36weeks or till delivery. This group was compared with a control group of 36 patients having similar history but not receiving any treatment. Pregnancy outcomes were recorded on a proforma. Results: 86 women were enrolled in the study 50 women in progesterone group and 36 in control group. The women in two groups were similar in term of age and parity. Mean gestational age at delivery was 36.4 in progesterone group and 34.3 in control group P = 0.004. Live birth rate was 94% in progesterone group as compared to 77.8% in control group. Perinatal mortality was significantly low in progesterone group P < 0.05. mean birth weight of babies was 2.66kg in progesterone group and 2.21kg in control goup with significant reduction in NICU admission in Progesterone group. P < 0.05. patient compliance and treatment acceptability was good with progesterone depot injections. Conclusion: Preterm birth is a major complication of pregnancy associated with perinatal mortality and morbidity. Progesterone therapy can be advocated for prevention of preterm labour in high risk group. There are no proven teratogenic effects on baby and patient compliance in terms of fianancial and treatment acceptability is good.
Keywords: Progesterone Preterm Labour.
